Clinical Trial Update: Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma

View source ↗

Summary

A completed clinical trial exploring glycosyltransferase as a potential prognostic biomarker for Neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Neuroblastoma | Status: COMPLETED